FDA Drug Application (021001) for AXERT by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number021001
Product Number001
FormTABLET;ORAL
DosageEQ 6.25MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAXERT
Active IngredientALMOTRIPTAN MALATE

Active IngredientCount
List of drugs with Active Ingredient ALMOTRIPTAN MALATE2


Back to FDA Applications sponsored by JANSSEN PHARMS